Hormonal Contraceptives Market

Hormonal Contraceptives Market - Analysis and Global Forecast to 2021

Report Code: UC 1458 Dec, 2018, by marketsandmarkets.com

Hormonal contraception is one of birth control methods which act on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception also results in changes in the uterus making it unlikely to develop pregnancy. Hormonal contraceptives are available in a variety of forms like patch worn on the skin, pill, injection, implant in the arm, or intrauterine devices. These are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

The global hormonal contraceptives market is likely to show significant growth during the forecast period. This is attributed to the urbanization, increasing user awareness, rise in menstruating population worldwide, and encouragement by government to use contraceptives.

The hormonal contraceptives market is segmented by method, by hormone, by end users and by geography. Based on method, the market is segmented into combined oral, oral, implanted, injected, intrauterine, transdermal patch, and vaginal ring contraceptives. The hormonal contraceptives market, by hormone is categorized into androgens, estrogens, progestrogens, gonadotropins, antiandrogens, and others. Based on end users, the market is segmented into hospitals, homecare, gynecology centers, clinics, and ambulatory surgical centers (ASC).

On the basis of regions, the global hormonal contraceptives market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa.

Some of the major players in the global hormonal contraceptives market  Amgen (U.S.), Bayer Healthcare Pharmaceuticals (Germany), Cipla Limited (India), Glenmark Pharmaceuticals (India), Lupin Pharmaceuticals, Inc (India), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Piramal Healthcare Limited (India), Sun Pharmaceutical Industries Ltd. (India), and Teva Pharmaceutical Industries (Israel).

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency & Pricing
    1.5 Limitation
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Methodology
    2.5 Market Data Validation and Data Triangulation
    2.6 Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraints
           5.3.3 Opportunities
           5.3.4 Challenges

6 Hormonal Contraceptives Market, By Method
    6.1 Introduction
    6.2 Combined Oral Contraceptives
    6.3 Oral Contraceptives
    6.4 Implanted Contraceptives
    6.5 Injected Contraceptives
    6.6 Intrauterine
    6.7 Trasdermal Patch
    6.8 Vaginal Ring

7 Hormonal Contraceptives Market, By Hormones
    7.1 Introduction
    7.2 Androgens
    7.3 Estrogens
    7.4 Progestogens
    7.5 Gonadotropins
    7.6 Antiandrogens
    7.7 Others

8 Hormonal Contraceptivesmarket, By End-Users
    8.1 Introduction
    8.2 Hospitals
    8.3 Homecare
    8.4 Gynecology Centers
    8.5 Clinics
    8.6 Ambulatory Surgical Centers (ASC)

9 Hormonal Contraceptives Market, By Geography
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of the World


10 Competitive Landscape
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 New Product Launches
             10.3.2 Expansions
             10.3.3 Agreements, Partnerships, and Collborations
             10.3.4 Acquisitions
             10.3.5 Others

11 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
     11.1 Introduction
     11.2 Amgen
     11.3 Bayer Healthcare Pharmaceuticals
     11.4 Cipla Limited
     11.5 Glenmark Pharmaceuticals
     11.6 Lupin Pharmaceuticals, Inc.
     11.7 Novartis AG
     11.8 Pfizer, Inc.
     11.9 Piramal Healthcare Limited
     11.10 Sun Pharmaceutical Industries Ltd.
     11.11 Teva Pharmaceutical Industries

12 Appendix
     12.1 Discussion Guide
     12.2 Introducing Rt: Real-Time Market Intelligence
     12.3 Available Customizations
     12.4 Related Reports

Note:
1. All the Above Markets Will Be Provided for the Years 2014, 2015, 2016, and 2021
2. Revenue for Companies Listed Under “Company Profile” Section (Chapter 10) Might Not Be Captured for Companies Whose Financial Data is Not Available in Public Domain
3. The Above Scope is Tentative and is Subject to Change as the Research Progresses


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1458
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hormonal Contraceptives Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved